December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Sabine Brookman-May: TAR-200 was safe and well tolerated, with encouraging preliminary efficacy in IR
Feb 21, 2024, 18:28

Sabine Brookman-May: TAR-200 was safe and well tolerated, with encouraging preliminary efficacy in IR

Sabine Brookman-May, Professor of Urology at the Ludwig-Maximilians University of Munchen, posted on X/Twitter:

Finally out: results of the legacy phase 1b study which built the groundwork for our ongoing phase 2 + 3 studies with the intravesical gemcitabine releasing system TAR-200.

TAR-200 was safe and well tolerated, with encouraging preliminary efficacy in IR.”

Image

Image

Source: Sabine Brookman-May/X